| |
Ipsos Reports 5.3% Organic Revenue Rise
Ipsos has reported a 14.3% increase in reported third quarter revenue, to EUR 601.5m from EUR 526.3m a year earlier. Organic revenue growth was 5.3%, while 8.0% resulted from currency effects.
 The company says results at the end of September show sustained growth, despite some 'challenges' in Europe and China. Over the first nine months, Ipsos posted a 13.4% increase in revenue to $1.72 billion, with 6.3% organic growth. Excluding the temporary net positive impact (ie in last year's figures) of Covid-related contracts, the group's underlying organic growth was 9.2% at the end of September.
Performance by Quarter
Performance by Quarter
| 2022 vs. 2021 |
| In
millions
of
euros |
Revenue
2022 |
Total growth |
Organic Growth |
| 1st quarter |
547.8
|
17.5%
|
12.3%(1) |
| 2nd quarter |
574.0
|
8.9%
|
2.1% |
| 3rd quarter |
601.5 |
14.3% |
5.3%* |
| Total Revenue |
1,723.3
|
13.4 %
|
6.3%*
|
|
|
(1) Covid-related contracts were maintained at least in part until March 31, 2022
* Underlying organic growth is 6.9% for the third quarter and 9.2% for the Nine-month 2022, excluding the temporary net positive impact of Covid-related contracts (specific pandemic monitoring projects for governments, minus contracts that could not be executed because of the health situation).
|
Performance by Region
Business in EMEA remains stable, while both North America and Latin America saw double-digit growth this year. Despite lockdowns hampering Ipsos' Chinese business, the group said its Asia-Pacific revenues had 'bounced back' in 2022.
Performance by Region
| 9-month 2022 vs. 2021 |
|
In millions of euros
|
9-month 2022 Revenue |
Contribution |
Total growth
|
Organic Growth
|
| EMEA |
743..3 |
43%
|
1.6% |
0%
|
| Americas |
678.7
|
39%
|
27.2% |
14% |
|
Asia Pacific
|
301.3
|
17%
|
18.5% |
10%
|
| Total Revenue |
1,723.3
|
100%
|
13.4%
|
6.3%
|
|
Performance by Audience
Ipsos has seen most growth in its consumer-facing segments, and double-digit growth in the Service Lines that focus on measuring and analyzing brand growth and expression. The group also noted 'good growth' in its work focusing on customers and employees.
Following the projects Ipsos carried out during the pandemic, its work among 'Citizens' has fallen back this year, while separately, the group's work with doctors and patients has seen 'moderate growth'.
Performance by Audience
| In millions of euros
|
9-month 2022 Revenue
|
Contribution
|
9-month 2022 vs. 2021
organic growth |
| Consumers 1 |
802.2
|
47%
|
12.5% |
| Customers and employees 2 |
352.6
|
20%
|
8% |
|
Citizens 3
|
283.3
|
16%
|
-7.5% |
| Doctors and patients4 |
285.1
|
17%
|
3.5% |
| Total Revenue |
1,723.3
|
100%
|
6.3%
|
|
|
Breakdown of Service Lines by audience segment:
1 - Brand Health Tracking, Creative Excellence, Innovation, Ipsos UU, Ipsos MMA, Market
Strategy & Understanding, Observer (excl. public sector), Social Intelligence Analytics, Strategy3
2 - Automotive & Mobility Development, Audience Measurement, Customer Experience, Channel
Performance (including Retail Performance and Mystery Shopping), Media development, Capabilities
3 - Public Affairs, Corporate Reputation
4 - Pharma (quantitative and qualitative)
|
Outlook
In a statement, Ipsos said that despite current economic uncertainties, it is confident on its ability to deliver the 2022-25 growth plan launched in June, and that it can deliver 'better performance' than promised at the start of the year - with anticipated organic growth closer to 6% than 5%.
'As the business prepares for 2023, we are in a good place. If some clients become more cautious for the coming months, we see no significant slowdown in our orders. Our order book at the end of September for 2023 is up by 8% compared to last year', the company stated.
Web site: www.ipsos.com .
|
